Black Rock Inc. Histogen Inc. Transaction History

Black Rock Inc.

  • $4.23 Trillion
  • Q1 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023
BUY
$0.79 - $1.35 $1 - $2
2 Added 0.01%
34,910 $28,000
Q2 2022

Aug 12, 2022
BUY
$2.15 - $8.4 $75,052 - $293,227
34,908 New
34,908 $79,000

Others Institutions Holding HSTO

# of Institutions
1
Shares Held
17
Call Options Held
0
Put Options Held
0
View Full List

About Histogen Inc.

HSTO Quotes by TradingView
  • Ticker HSTO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,497,450
  • Market Cap $524K
  • Description
  • Histogen Inc., a clinical-stage therapeutics company, focuses on developing proprietary hypoxia-generated growth factor technology platform and stem cell-free biologic products. It offers HST-003, a human extracellular matrix, which is in Phase 1/2 clinical trial to treat articular cartilage defects in the knee; HST-004, a cell conditioned media...
More about HSTO
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email